Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 1250.00 | 859.67 | 1948.00 | 2002.25 | 0.9729 | 0.9555 |
| SK-BR-3 | Lapatinib | 1 | uM | 7 | 1250.00 | 859.67 | 1084.00 | 2002.25 | 0.5414 | 0.2094 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 1250.00 | 859.67 | 835.00 | 2002.25 | 0.4170 | -0.0236 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 7 | 1250.00 | 859.67 | 1550.00 | 2002.25 | 0.7741 | 0.6214 |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 1776.00 | 2002.25 | 0.8870 | 0.8128 | |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 2.00 | 2002.25 | 0.0010 | -0.9931 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 5.00 | 3831.50 | 0.0013 | -0.9969 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 2978.00 | 3831.50 | 0.7772 | 0.5645 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3717.00 | 3831.50 | 0.9701 | 0.9417 | |
| SK-BR-3 | 17-AAG | 3.1623 | uM | 7 | 2500.00 | 1881.33 | 1789.00 | 3831.50 | 0.4669 | -0.0479 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 7 | 2500.00 | 1881.33 | 3604.00 | 3831.50 | 0.9406 | 0.8842 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 7 | 2500.00 | 1881.33 | 2518.00 | 3831.50 | 0.6572 | 0.3285 |
| SK-BR-3 | 17-AAG | 0.0033113 | uM | 7 | 2500.00 | 1881.33 | 2780.00 | 3831.50 | 0.7256 | 0.4630 |
| SK-BR-3 | Linsitinib | 1 | uM | 7 | 2500.00 | 1881.33 | 3021.00 | 3831.50 | 0.7885 | 0.5865 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 7 | 2500.00 | 1881.33 | 3957.00 | 3831.50 | 1.0328 | 1.0638 |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 4232.00 | 3831.50 | 1.1045 | 1.2035 | |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 7 | 2500.00 | 1881.33 | 4323.00 | 3831.50 | 1.1283 | 1.2496 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 7 | 2500.00 | 1881.33 | 4081.00 | 3831.50 | 1.0651 | 1.1268 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 2500.00 | 1881.33 | 2199.00 | 3831.50 | 0.5739 | 0.1642 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 7 | 2500.00 | 1881.33 | 4044.00 | 3831.50 | 1.0555 | 1.1080 |
| SK-BR-3 | 17-AAG | 10 | uM | 7 | 2500.00 | 1881.33 | 1946.00 | 3831.50 | 0.5079 | 0.0335 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 7 | 2500.00 | 1881.33 | 2533.00 | 3831.50 | 0.6611 | 0.3362 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 7 | 2500.00 | 1881.33 | 1910.00 | 3831.50 | 0.4985 | 0.0148 |
| SK-BR-3 | Linsitinib | 10 | uM | 7 | 2500.00 | 1881.33 | 3111.00 | 3831.50 | 0.8120 | 0.6326 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 7 | 2500.00 | 1881.33 | 3767.00 | 3831.50 | 0.9832 | 0.9672 |